ALK-Positive Anaplastic Large Cell Lymphoma

Also known as: ALK+ Anaplastic Large Cell Lymphoma / Anaplastic Lymphoma Kinase Positive (ALK +) Anaplastic Large Cell Lymphoma / Anaplastic Large Cell Lymphoma, ALK-Positive / Large cell anaplastic lymphoma T cell and Null cell type (disorder) / Anaplastic large-cell lymphoma / Anaplastic large cell lymphoma, T cell and Null cell type (morphologic abnormality) / Large cell anaplastic lymphoma (disorder) / Lymphoma, Large-Cell, Anaplastic

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB13906	Aloe vera leaf	Not Available	Active Not Recruiting	1
DB00126	Ascorbic acid	Not Available	Active Not Recruiting	1
DB09462	Glycerin	Not Available	Active Not Recruiting	1
DB02701	Nicotinamide	Not Available	Active Not Recruiting	1
DB00162	Vitamin A	Not Available	Active Not Recruiting	1
DB02379	Beta-D-Glucose	1 / 2	Completed	1
DB08870	Brentuximab vedotin	1 / 2	Terminated	1
DB08870	Brentuximab vedotin	1 / 2	Withdrawn	1
DB12267	Brigatinib	1 / 2	Recruiting	1
DB12267	Brigatinib	1 / 2	Withdrawn	1
DB14776	Camrelizumab	1 / 2	Unknown Status	1
DB09063	Ceritinib	1 / 2	Withdrawn	1
DB14681	Cortisone	1 / 2	Completed	1
DB00531	Cyclophosphamide	1 / 2	Completed	1
DB00531	Cyclophosphamide	1 / 2	Recruiting	1
DB00997	Doxorubicin	1 / 2	Completed	1
DB00997	Doxorubicin	1 / 2	Recruiting	1
DB00773	Etoposide	1 / 2	Completed	1
DB00619	Imatinib	1 / 2	Terminated	1
DB00480	Lenalidomide	1 / 2	Completed	1
DB00480	Lenalidomide	1 / 2	Unknown Status	1
DB00635	Prednisone	1 / 2	Completed	1
DB00635	Prednisone	1 / 2	Recruiting	1
DB00073	Rituximab	1 / 2	Recruiting	1
DB14765	Rivoceranib	1 / 2	Unknown Status	1
DB14546	Sulfate ion	1 / 2	Completed	1
DB14922	Tislelizumab	1 / 2	Unknown Status	1
DB15043	Toripalimab	1 / 2	Recruiting	1
DB00541	Vincristine	1 / 2	Completed	1
DB00541	Vincristine	1 / 2	Recruiting	1
DB02379	Beta-D-Glucose	2	Active Not Recruiting	1
DB02379	Beta-D-Glucose	2	Completed	1
DB08870	Brentuximab vedotin	2	Active Not Recruiting	1
DB08870	Brentuximab vedotin	2	Completed	1
DB12267	Brigatinib	2	Withdrawn	1
DB14681	Cortisone	2	Active Not Recruiting	1
DB08865	Crizotinib	2	Completed	2
DB00531	Cyclophosphamide	2	Active Not Recruiting	1
DB00531	Cyclophosphamide	2	Completed	1
DB00987	Cytarabine	2	Completed	1
DB00694	Daunorubicin	2	Active Not Recruiting	1
DB01234	Dexamethasone	2	Completed	1
DB00997	Doxorubicin	2	Active Not Recruiting	1
DB00997	Doxorubicin	2	Completed	1
DB00773	Etoposide	2	Active Not Recruiting	1
DB00773	Etoposide	2	Completed	1
DB01181	Ifosfamide	2	Completed	1
DB12130	Lorlatinib	2	Recruiting	1
DB16620	Methopterin	2	Completed	1
DB00563	Methotrexate	2	Completed	1
DB00635	Prednisone	2	Active Not Recruiting	1
DB13896	Talimogene laherparepvec	2	Active Not Recruiting	1
DB14922	Tislelizumab	2	Completed	1
DB00135	Tyrosine	2	Completed	1
DB08865	Crizotinib	4	Unknown Status	1
DB00773	Etoposide	4	Unknown Status	1